Home
  >  
Section 4
  >  
Chapter 3,472

In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B

Moore, C.B.; Walls, C.M.; Denning, D.W.

Antimicrobial Agents and ChemoTherapy 44(2): 441-443

2000

ISSN/ISBN: 0066-4804
PMID: 10639380
DOI: 10.1128/aac.44.2.441-443.2000
Accession: 003471891
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The in vitro activity of BMS-207147 against 80 clinical isolates of Aspergillus (50 A. fumigatus and 10 each of A. terreus, A. flavus and A. niger) was compared with that of itraconazole and amphotericin B, using a validated microtitre method. Geometric mean minimum inhibitory concentrations (MICs in micro g/ml) were as follows: 1.71 for BMS-207147, 0.67 for itraconazole and 0.63 for amphotericin B. The range of concentrations of each drug was 0.125 to >16 micro g/ml.

PDF emailed within 0-6 h: $19.90




Related References

Moore, C.B.; Law, D.; Denning, D.W. 1993: In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp Journal of Antimicrobial ChemoTherapy 32(6): 831-836
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B Journal of Antimicrobial ChemoTherapy 42(1): 91-94
Moore, C.B.; Walls, C.M.; Denning, D.W. 2001: In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B Antimicrobial Agents and ChemoTherapy 45(6): 1882-1885
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1997: In vitro activity of Sch-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp Antimicrobial Agents and Chemotherapy 41(5): 1124-1126
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1997: In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp Antimicrobial Agents and ChemoTherapy 41(5): 1124-1126
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In Vitro Activity of the Echinocandin Antifungal Agent Ly303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp Antimicrobial Agents and Chemotherapy 42(10): 2726-2730
Cuenca-Estrella, M.; Rodríguez-Tudela, J.L.; Mellado, E.; Martínez-Suárez, J.V.; Monzón, A. 1998: Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus Journal of Antimicrobial ChemoTherapy 42(4): 531-533
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp Antimicrobial Agents and ChemoTherapy 42(10): 2726-2730
García-Martos, P.; García-Agudo, L.; Gutiérrez-Calzada, J.ús.; Ruiz-Aragón, J.ús.; Saldarreaga, A.; Marín, P. 2005: In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method Enfermedades Infecciosas y Microbiologia Clinica 23(1): 15-18
Chryssanthou, E. 1997: In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole Scandinavian Journal of Infectious Diseases 29(5): 509-512
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1999: Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole Antimicrobial Agents and ChemoTherapy 43(5): 1264-1266
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1999: Comparison of In Vitro Activity of Liposomal Nystatin against Aspergillus Species with Those of Nystatin, Amphotericin B (Ab) Deoxycholate, Ab Colloidal Dispersion, Liposomal Ab, Ab Lipid Complex, and Itraconazole Antimicrobial Agents and Chemotherapy 43(5): 1264-1266
Venkateswarlu, K.; Denning, D.W.; Kelly, S.L. 1997: In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei Journal of Antimicrobial ChemoTherapy 39(6): 731-736
Rudramurthy, S.M.; Jatana, M.; Singh, R.; Chakrabarti, A. 2013: In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole Mycoses 56(1): 39-46
Wang, H.-C.; Hsieh, M.-I.; Choi, P.-C.; Wu, C.-J. 2018: Comparison of the Sensititre YeastOne and CLSi M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species Journal of Clinical Microbiology 56(10)
Abraham, O.C.; Manavathu, E.K.; Cutright, J.L.; Chandrasekar, P.H. 1999: In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B Diagnostic Microbiology and Infectious Disease 33(1): 7-11
Abraham, O.C.; Manavathu, E.K.; Chandrasekar, P.H. 1997: In-vitro activities of voriconazole, itraconazole and amphotericin B against Aspergillus species Clinical Infectious Diseases 25(2): 378
Kantarcioğlu, A.S.; Yucel, A. 2002: In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species Journal of ChemoTherapy 14(6): 562-567
Denning, D.W.; Hanson, L.H.; Stevens, D.A. 1990: In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 9(9): 693-697
Boon-Long, J.; Mekha, N.; Poonwan, N.; Kusum, M.; Mikami, Y.; Yazawa, K.; Konyama, K. 1996: In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine Mycoses 39(11-12): 453-456